Kyoto University Innovation Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
13

- Investments
-
115
- Portfolio
-
61
- Exits
-
12

Kyoto University Innovation Capital General Information
Company Description
Founded in 2014, Kyoto University Innovation Capital is a venture capital firm based in Kyoto, Japan. The firm seeks to support and invest in Kyoto University startups with a focus on the healthcare, medical devices, biotechnology, drug discovery, internet of things, artificial intelligence, machinery, clean technology, energy, new material, food, and agriculture sectors. The firm also seeks to invest in spin-off research outcomes of Kyoto University.
Business Details
Website
www.kyoto-unicap.co.jpYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 36-1 Yoshida Honmachi
- Sakyo-ku
- Kyoto, 606-8317
- Japan
Kyoto University Innovation Capital Investments (115)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Eurus Therapeutics | 27-Jun-2025 | Early Stage VC | Drug Discovery | Startup | ||
Phytolipid Technologies | 27-Jun-2025 | Agricultural Chemicals | Generating Revenue | |||
BiPSEE | 26-Jun-2025 | Therapeutic Devices | Generating Revenue | |||
RegCell | 18-Mar-2025 | Biotechnology | Pre-Clinical Trials | |||
Holo Bio | 25-Feb-2025 | Biotechnology | Generating Revenue | |||
JiMED | 12-Feb-2025 | Monitoring Equipment | Generating Revenue | |||
Enu Pharma | 31-Jan-2025 | Drug Delivery | Generating Revenue | |||
RadioNano Therapeutics | 23-Dec-2024 | Drug Discovery | Clinical Trials - General | |||
Koala Tech | 18-Nov-2024 | Early Stage VC | Production (Semiconductors) | Generating Revenue | ||
Rhinoflux | 30-Oct-2024 | Seed Round | Alternative Energy Equipment | Generating Revenue |
Kyoto University Innovation Capital Exits (12)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Chordia Therapeutics | 14-Jun-2024 | IPO | |
Fimecs | 26-Mar-2024 | ||
Cuorips | 27-Jun-2023 | ||
ACT Genomics | 30-Dec-2022 | ||
Cend Therapeutics | 15-Sep-2022 | ||
AFI Technology | 01-Jul-2022 | ||
PPMX (Drug Discovery) | 22-Jun-2021 | ||
Drawbridge Health | 25-May-2021 | ||
PrediXT | 20-Apr-2020 | Out of Business | |
Kyoto Drug Discovery & Development | Secondary Transaction - Private |
Kyoto University Innovation Capital Investments by Industry, Year, and Region
Kyoto University Innovation Capital Co-Investors (159)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
SMBC Venture Capital | 12 |
![]() |
![]() |
||
Mitsubishi UFJ Capital |
![]() |
![]() |
|||
Global Brain |
![]() |
![]() |
|||
Kyoto Capital Partners (Japan) |
![]() |
![]() |
|||
JIC Venture Growth Investments |
![]() |
![]() |
Kyoto University Innovation Capital FAQs
-
What is Kyoto University Innovation Capital?
Founded in 2014, Kyoto University Innovation Capital is a venture capital firm based in Kyoto, Japan.
-
When was Kyoto University Innovation Capital founded?
Kyoto University Innovation Capital was founded in 2014.
-
Where is Kyoto University Innovation Capital headquartered?
Kyoto University Innovation Capital is headquartered in Kyoto, Japan.
-
What is Kyoto University Innovation Capital's total asset value?
Kyoto University Innovation Capital has around
in total assets under management. -
How many investments has Kyoto University Innovation Capital made?
Kyoto University Innovation Capital has made 115 investments.
-
What has Kyoto University Innovation Capital invested in?
Kyoto University Innovation Capital has made numerous investments in companies like Eurus Therapeutics, Phytolipid Technologies, and BiPSEE within the Drug Discovery, Agricultural Chemicals, and Therapeutic Devices industries.
-
What has Kyoto University Innovation Capital invested in recently?
Kyoto University Innovation Capital's latest investment was on 27-Jun-2025 in Eurus Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »